Magnetic Resonance Imaging-Based Prediction of Uterine Fibroid Size Reduction by Relugolix Using T2-Weighted Signal Intensity Ratio: A Retrospective Multicenter Study
Journal of Clinical Gynecology and Obstetrics · 2025
DOI: 10.14740/jcgo1506 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Gynecology and Obstetrics, 2025. Verfasst von Jun Matsukawa und 9 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Matsukawa, J., Hiraka, T., Sugiyama, A., Kaneko, H., Nakamura, F., Nakai, N., Takahashi, K., Takehara, I., Kanoto, M., & Nagase, S. (2025). Magnetic Resonance Imaging-Based Prediction of Uterine Fibroid Size Reduction by Relugolix Using T2-Weighted Signal Intensity Ratio: A Retrospective Multicenter Study. Journal of Clinical Gynecology and Obstetrics. https://doi.org/10.14740/jcgo1506
Vancouver
Matsukawa J, Hiraka T, Sugiyama A, Kaneko H, Nakamura F, Nakai N, et al. Magnetic Resonance Imaging-Based Prediction of Uterine Fibroid Size Reduction by Relugolix Using T2-Weighted Signal Intensity Ratio: A Retrospective Multicenter Study. Journal of Clinical Gynecology and Obstetrics. 2025. doi:10.14740/jcgo1506
BibTeX
@article{Matsukawa2025,
author = {Matsukawa, Jun and Hiraka, Toshitada and Sugiyama, Akiko and Kaneko, Hiromu and Nakamura, Fumihiro and Nakai, Nanako and Takahashi, Kyoko and Takehara, Isao and Kanoto, Masafumi and Nagase, Satoru},
title = {Magnetic Resonance Imaging-Based Prediction of Uterine Fibroid Size Reduction by Relugolix Using T2-Weighted Signal Intensity Ratio: A Retrospective Multicenter Study},
journal = {Journal of Clinical Gynecology and Obstetrics},
year = {2025},
doi = {10.14740/jcgo1506}
}
EUVIMED